Last reviewed · How we verify
"AS-Probionorm"
AS-Probionorm is a probiotic formulation that restores beneficial gut microbiota to support digestive health and immune function.
AS-Probionorm is a probiotic formulation that restores beneficial gut microbiota to support digestive health and immune function. Used for Gastrointestinal health maintenance, Digestive support.
At a glance
| Generic name | "AS-Probionorm" |
|---|---|
| Sponsor | Industrial Microbiology LLP |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
The product contains a consortium of beneficial bacterial strains designed to colonize the gastrointestinal tract, restore microbial balance, and enhance intestinal barrier function. By replenishing commensal microorganisms, it aims to improve digestion, reduce pathogenic bacterial overgrowth, and modulate local and systemic immune responses.
Approved indications
- Gastrointestinal health maintenance
- Digestive support
Common side effects
- Gastrointestinal bloating
- Mild abdominal discomfort
Key clinical trials
- INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM" (PHASE2)
- Study of the Safety and Tolerability of the Broad-spectrum Probiotic Medicine "AS-Probionorm" (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- "AS-Probionorm" CI brief — competitive landscape report
- "AS-Probionorm" updates RSS · CI watch RSS
- Industrial Microbiology LLP portfolio CI